185 related articles for article (PubMed ID: 17973937)
1. Bioavailable testosterone is associated with a reduced risk of amnestic mild cognitive impairment in older men.
Chu LW; Tam S; Lee PW; Wong RL; Yik PY; Tsui W; Song Y; Cheung BM; Morley JE; Lam KS
Clin Endocrinol (Oxf); 2008 Apr; 68(4):589-98. PubMed ID: 17973937
[TBL] [Abstract][Full Text] [Related]
2. Late-life body mass index and waist circumference in amnestic mild cognitive impairment and Alzheimer's disease.
Chu LW; Tam S; Lee PW; Yik PY; Song Y; Cheung BM; Lam KS
J Alzheimers Dis; 2009; 17(1):223-32. PubMed ID: 19221407
[TBL] [Abstract][Full Text] [Related]
3. Serum total and bioavailable testosterone levels, central obesity, and muscle strength changes with aging in healthy Chinese men.
Chu LW; Tam S; Kung AW; Lo S; Fan S; Wong RL; Morley JE; Lam KS
J Am Geriatr Soc; 2008 Jul; 56(7):1286-91. PubMed ID: 18482300
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E epsilon4, Alzheimer's disease, and cognitive performance in elderly Mexican Mestizos.
Villalpando-Berumen JM; Mejia-Arango S; Aguilar-Salinas CA; Ordonez-Sanchez ML; Gutierrez-Robledo LM
J Am Geriatr Soc; 2008 Apr; 56(4):677-82. PubMed ID: 18205760
[TBL] [Abstract][Full Text] [Related]
5. Mortality in amnestic mild cognitive impairment: a prospective community study.
Hunderfund AL; Roberts RO; Slusser TC; Leibson CL; Geda YE; Ivnik RJ; Tangalos EG; Petersen RC
Neurology; 2006 Nov; 67(10):1764-8. PubMed ID: 17130407
[TBL] [Abstract][Full Text] [Related]
6. Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.
Graff-Radford NR; Crook JE; Lucas J; Boeve BF; Knopman DS; Ivnik RJ; Smith GE; Younkin LH; Petersen RC; Younkin SG
Arch Neurol; 2007 Mar; 64(3):354-62. PubMed ID: 17353377
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E epsilon4 and testosterone interact in the risk of Alzheimer's disease in men.
Hogervorst E; Lehmann DJ; Warden DR; McBroom J; Smith AD
Int J Geriatr Psychiatry; 2002 Oct; 17(10):938-40. PubMed ID: 12325053
[TBL] [Abstract][Full Text] [Related]
8. Serum total testosterone is lower in men with Alzheimer's disease.
Hogervorst E; Williams J; Budge M; Barnetson L; Combrinck M; Smith AD
Neuro Endocrinol Lett; 2001 Jun; 22(3):163-8. PubMed ID: 11449190
[TBL] [Abstract][Full Text] [Related]
9. [Cognitive function, serum BDNF levels and BDNF gene Val66Met polymorphism in amnestic mild cognitive impairment].
Yu H; Zhang ZJ; Shi YM; Bai F; Qian Y; Yuan YG; Deng LL
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Apr; 33(4):321-5. PubMed ID: 18460776
[TBL] [Abstract][Full Text] [Related]
10. Serum amyloid p component as a biomarker in mild cognitive impairment and Alzheimer's disease.
Verwey NA; Schuitemaker A; van der Flier WM; Mulder SD; Mulder C; Hack CE; Scheltens P; Blankenstein MA; Veerhuis R
Dement Geriatr Cogn Disord; 2008; 26(6):522-7. PubMed ID: 19052452
[TBL] [Abstract][Full Text] [Related]
11. Higher serum free testosterone is associated with better cognitive function in older men, while total testosterone is not. The Health In Men Study.
Yeap BB; Almeida OP; Hyde Z; Chubb SA; Hankey GJ; Jamrozik K; Flicker L
Clin Endocrinol (Oxf); 2008 Mar; 68(3):404-12. PubMed ID: 17888021
[TBL] [Abstract][Full Text] [Related]
12. Bioavailable testosterone predicts a lower risk of Alzheimer's disease in older men.
Chu LW; Tam S; Wong RL; Yik PY; Song Y; Cheung BM; Morley JE; Lam KS
J Alzheimers Dis; 2010; 21(4):1335-45. PubMed ID: 21504130
[TBL] [Abstract][Full Text] [Related]
13. The functional anatomy of divided attention in amnestic mild cognitive impairment.
Dannhauser TM; Walker Z; Stevens T; Lee L; Seal M; Shergill SS
Brain; 2005 Jun; 128(Pt 6):1418-27. PubMed ID: 15705612
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal study of amnesic patients at high risk for Alzheimer's disease: clinical, neuropsychological and magnetic resonance spectroscopy features.
Rami L; Gómez-Anson B; Sanchez-Valle R; Bosch B; Monte GC; Lladó A; Molinuevo JL
Dement Geriatr Cogn Disord; 2007; 24(5):402-10. PubMed ID: 17934274
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of hippocampal serotonin metabolism in mild cognitive impairment.
Truchot L; Costes SN; Zimmer L; Laurent B; Le Bars D; Thomas-Antérion C; Croisile B; Mercier B; Hermier M; Vighetto A; Krolak-Salmon P
Neurology; 2007 Sep; 69(10):1012-7. PubMed ID: 17785670
[TBL] [Abstract][Full Text] [Related]
16. Low free testosterone is an independent risk factor for Alzheimer's disease.
Hogervorst E; Bandelow S; Combrinck M; Smith AD
Exp Gerontol; 2004; 39(11-12):1633-9. PubMed ID: 15582279
[TBL] [Abstract][Full Text] [Related]
17. The assessment of recognition memory using the Remember/Know procedure in amnestic mild cognitive impairment and probable Alzheimer's disease.
Hudon C; Belleville S; Gauthier S
Brain Cogn; 2009 Jun; 70(1):171-9. PubMed ID: 19250730
[TBL] [Abstract][Full Text] [Related]
18. Interaction between testosterone and apolipoprotein E epsilon4 status on cognition in healthy older men.
Burkhardt MS; Foster JK; Clarnette RM; Chubb SA; Bruce DG; Drummond PD; Martins RN; Yeap BB
J Clin Endocrinol Metab; 2006 Mar; 91(3):1168-72. PubMed ID: 16368754
[TBL] [Abstract][Full Text] [Related]
19. Balance features in Alzheimer's disease and amnestic mild cognitive impairment.
Leandri M; Cammisuli S; Cammarata S; Baratto L; Campbell J; Simonini M; Tabaton M
J Alzheimers Dis; 2009; 16(1):113-20. PubMed ID: 19158427
[TBL] [Abstract][Full Text] [Related]
20. Endogenous sex hormones, cognitive decline, and future dementia in old men.
Geerlings MI; Strozyk D; Masaki K; Remaley AT; Petrovitch H; Ross GW; White LR; Launer LJ
Ann Neurol; 2006 Sep; 60(3):346-55. PubMed ID: 16865684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
